Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear, accessible, and well-structured, rather than the scope of the content, which spans approximately 500 pages. The Concise Guide summarises the key pharmacological properties of around 1900 human drug targets, and nearly 7000 interactions, involving around 4400 ligands. While the content is a substantially condensed version of the more detailed information and links available at the www.guidetopharmacology.org website, the printed guide serves as a permanent, citable, point-in-time record, that remains stable despite ongoing updates to the online database. The full contents of this publication can be found at https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70230. The Concise Guides provide expert-curated recommendations of ‘Gold Standard’ selective pharmacological tools, available either commercially or as donations, which enable the identification of individual drug targets or families of drug targets. While the Concise Guide offers a more streamlined overview, more comprehensive information, including detailed pharmacological profiles and links to multiple online databases, is available through the Guide to Pharmacology website. The 2025/26 edition of the Concise Guide is based on material current as of mid-2025, and supersedes all previous editions, including the 2023/24 Guide, and earlier Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), and as such provides official IUPHAR classification and nomenclature for human drug targets, where applicable. G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. Each section includes nomenclature guidance, concise summaries, information of the best available pharmacological tools, key references, and suggestions for further reading.
The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors
Alexander, Stephen P. H.;Davenport, Anthony P.;Kelly, Eamonn;Gibb, Alasdair J.;Mathie, Alistair A.;Peach, Chloe J.;Veale, Emma L.;Armstrong, Jane F.;Faccenda, Elena;Harding, Simon D.;Southan, Christopher;Davies, Jamie A.;Abbracchio, Maria Pia;Abraham, George R.;Agoulnik, Alexander;Alexander, Wayne;Al‐hosaini, Khaled;Bäck, Magnus;Baker, Jillian G.;Barnes, Nicholas M.;Bathgate, Ross;Beaulieu, Jean‐Martin;Beck‐Sickinger, Annette G.;Behrens, Maik;Bennett, Kirstie A.;Bernstein, Kenneth E.;Bettler, Bernhard;Birdsall, Nigel J. M.;Blaho, Victoria A.;Bonaventure, Pascal;Boulay, Francois;Bousquet, Corinne;Bräuner‐Osborne, Hans;Brown, Andrew J.;Burnstock, Geoffrey;Busnelli, Marta;Caló, Girolamo;Caruso, Vanni;Castaño, Justo P.;Catt, Kevin J.;Ceruti, Stefania;Chazot, Paul;Chiang, Nan;Chini, Bice;Christopoulos, Arthur;Chun, Jerold;Cianciulli, Antonia;Civelli, Olivier;Clapp, Lucie H.;Couture, Réjean;Cox, Helen M.;Csaba, Zsolt;Dahlgren, Claes;Dautzenberg, Frank M.;Dent, Gordon;Douglas, Steven D.;Dournaud, Pascal;Dubocovich, Margarita L.;Eguchi, Satoru;Escher, Emanuel;Filardo, Edward J.;Fong, Tung;Forsman, Huamei Fu;Fumagalli, Marta;Gainetdinov, Raul R.;Garelja, Michael L.;de Gasparo, Marc;Gbahou, Florence;Gerard, Craig;Gershengorn, Marvin;Glass, Michelle;Gloriam, David E.;Gobeil, Fernand;Goodfriend, Theodore L.;Goudet, Cyril;Grätz, Lukas;Gregory, Karen J.;Gruber, Christian;Gundlach, Andrew L.;Hamann, Jörg;Hanson, Julien;Hartman, Deborah S.;Hauger, Richard L.;Hay, Debbie L.;Heinemann, Akos;Heitman, Laura;Herr, Deron R.;Hollenberg, Morley D.;Holliday, Nicholas D.;Holst, Birgitte;Horiuchi, Mastgugu;Hoyer, Daniel;Hunyady, László;Husain, Ahsan;IJzerman, Adriaan P.;Inagami, Tadashi;Insel, Paul A.;Jacobson, Kenneth A.;Jacobson, Laura H.;Jensen, Robert T.;Jockers, Ralf;Jonnalagadda, Deepa;Karnik, Sadashiva;Kaupmann, Klemens;Kemp, Jacqueline;Kennedy, Charles;Kihara, Yasuyuki;Kinsolving, Julia;Kitazawa, Takio;Kozielewicz, Pawel;Kreienkamp, Hans‐Jürgen;Kukkonen, Jyrki P.;Laishram, Luxmichan;Langenhan, Tobias;Langmead, Christopher J.;Larhammar, Dan;Leach, Katie;Lecca, Davide;Lee, John D.;Leeman, Susan E.;Leprince, Jérôme;Leurs, Rob;Li, Xaria X.;Liebscher, Ines;Lolait, Stephen J.;Lupp, Amelie;Macrae, Robyn;Maguire, Janet J.;Malfacini, Davide;Manning, Maurice;Marangon, Davide;Martemyanov, Kirill;Mazella, Jean;McArdle, Craig A.;Melmed, Shlomo;Michel, Martin C.;Miller, Laurence J.;Mitolo, Vincenzo;Mouillac, Bernard;Müller, Christa E.;Murphy, Philip M.;Nahon, Jean‐Louis;Neubig, Richard R.;Ngo, Tony;Norel, Xavier;Nyimanu, Duuamene;O'Carroll, Anne‐Marie;Offermanns, Stefan;Panaro, Maria Antonietta;Parmentier, Marc;Perry‐Hauser, Nicole;Pertwee, Roger G.;Pin, Jean‐Philippe;Prossnitz, Eric R.;Qin, Helena Chengxue;Quinn, Mark;Raffaele, Stefano;Ramachandran, Rithwik;Ray, Manisha;Reinscheid, Rainer K.;Buzón, Alejandro Romeral;Rondard, Philippe;Rosenkilde, Mette M.;Rovati, G. Enrico;Ruzza, Chiara;Sanger, Gareth J.;Scholz, Nicole;Schöneberg, Torsten;Schulte, Gunnar;Schulz, Stefan;Segaloff, Deborah L.;Serhan, Charles N.;Shukla, Arun K.;Singh, Khuraijam Dhanachandra;Smith, Craig M.;Smith, Nicola J.;Stäubert, Claudia;Stoddart, Leigh A.;Sugimoto, Yukihiko;Summers, Roger;Tan, Valerie P.;Thal, David M.;Thomas, Walter ( Wally);Timmermans, Pieter B. M. W. M.;Tirupula, Kalyan;Toll, Lawrence;Tulipano, Giovanni;Unal, Hamiyet;Unger, Thomas;Valant, Celine;Vanderheyden, Patrick;Vaudry, David;Vaudry, Hubert;Verbalis, Joseph G.;Vilardaga, Jean‐Pierre;Walker, Christopher S.;Wang, Ji Ming;Ward, Donald T.;Wester, Hans‐Jürgen;Willars, Gary B.;Williams, Tom Lloyd;Woodruff, Trent M.;Wu, Huixian;Yang, Cheng;Yao, Chengcan;Ye, Richard D.;Zaidman, Nathan
2025-01-01
Abstract
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear, accessible, and well-structured, rather than the scope of the content, which spans approximately 500 pages. The Concise Guide summarises the key pharmacological properties of around 1900 human drug targets, and nearly 7000 interactions, involving around 4400 ligands. While the content is a substantially condensed version of the more detailed information and links available at the www.guidetopharmacology.org website, the printed guide serves as a permanent, citable, point-in-time record, that remains stable despite ongoing updates to the online database. The full contents of this publication can be found at https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70230. The Concise Guides provide expert-curated recommendations of ‘Gold Standard’ selective pharmacological tools, available either commercially or as donations, which enable the identification of individual drug targets or families of drug targets. While the Concise Guide offers a more streamlined overview, more comprehensive information, including detailed pharmacological profiles and links to multiple online databases, is available through the Guide to Pharmacology website. The 2025/26 edition of the Concise Guide is based on material current as of mid-2025, and supersedes all previous editions, including the 2023/24 Guide, and earlier Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), and as such provides official IUPHAR classification and nomenclature for human drug targets, where applicable. G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. Each section includes nomenclature guidance, concise summaries, information of the best available pharmacological tools, key references, and suggestions for further reading.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/584480
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
ND
24
26
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.